Stockreport

SAB Biotherapeutics Announces Departure of Chief Financial Officer

SAB Biotherapeutics, Inc.  (SABS) 
PDF MIAMI, May 30, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunother [Read more]